Disparities in the use of a mHealth medication adherence promotion intervention for low-income adults with type 2 diabetes.
about
Assessing the Medication Adherence App Marketplace From the Health Professional and Consumer Vantage Points.Development and Usability of REACH: A Tailored Theory-Based Text Messaging Intervention for Disadvantaged Adults With Type 2 Diabetes.Patterns of User Engagement with Mobile- and Web-Delivered Self-Care Interventions for Adults with T2DM: A Review of the Literature.The MEssaging for Diabetes (MED) intervention improves short-term medication adherence among low-income adults with type 2 diabetes.Participation of Racial and Ethnic Minorities in Technology-Based Interventions to Self-Manage Type 2 Diabetes: A Scoping Review.The Emergence of Personalized Health Technology.The MEssaging for Diabetes Intervention Reduced Barriers to Medication Adherence Among Low-Income, Diverse Adults With Type 2."I don't have to explain, people understand": Acceptability and Cultural Relevance of a Mobile Health Lifestyle Intervention for Filipinos with Type 2 Diabetes.The Impact of a Mobile Diabetes Health Intervention on Diabetes Distress and Depression Among Adults: Secondary Analysis of a Cluster Randomized Controlled Trial.mHealth Intervention Elements and User Characteristics Determine Utility: A Mixed-Methods Analysis.Exploring Perceived Barriers to Medication Adherence and the Use of Mobile Technology in Underserved Patients With Chronic Conditions.Mobile Diabetes Intervention Study of Patient Engagement and Impact on Blood Glucose: Mixed Methods Analysis.Effectiveness of the mHealth technology in improvement of healthy behaviors in an elderly population-a systematic review.Factors Affecting Follow-Up Compliance in Patients After Endovascular Aneurysm Repair."The Doctor Needs to Know": Acceptability of Smartphone Location Tracking for Care Coordination.Public attitudes towards mobile health in Singapore: a cross-sectional study
P2860
Q33454109-78D55EF5-BE0D-4E2D-B813-C834FBBA568EQ37277710-35F26F94-9E0D-4491-B347-C31306A1BD73Q37608501-B20BB28B-BB49-469B-B9A1-F7FE88890CFBQ38378929-0E8E3C9F-D02F-4815-93A3-360C9B422EE0Q38615978-2DAE1FA4-C06B-402B-B8DB-AEAFD55C2652Q39777070-8D91AE89-0CC9-4464-A320-28CFAE417510Q41692675-0D284EBD-8C7F-430C-AC26-86F66AA1948DQ42360864-8811244D-B53A-4A0F-A636-12C52C03C56BQ47101103-F4B6D126-C39A-4851-8A24-28A40F906FEFQ47113727-F304BDAF-E526-4AAC-9116-AAC67D730090Q47356588-81353FD1-9A46-4972-8F03-DB8CEBB397FFQ48113366-D4C6900A-3D9B-4109-957D-90DD52A160E6Q49516466-80AD169C-9F2B-4E2B-A462-983C44AA038EQ52587035-38F5CAD6-27FE-4C4B-906F-AB55DA33827CQ55294678-90B639B9-7769-49B1-9328-3B3B4E72367FQ58550642-EE4E0264-4F8A-4D49-A534-FF10AD059EB0
P2860
Disparities in the use of a mHealth medication adherence promotion intervention for low-income adults with type 2 diabetes.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 17 July 2015
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Disparities in the use of a mH ...... e adults with type 2 diabetes.
@en
Disparities in the use of a mH ...... e adults with type 2 diabetes.
@nl
type
label
Disparities in the use of a mH ...... e adults with type 2 diabetes.
@en
Disparities in the use of a mH ...... e adults with type 2 diabetes.
@nl
prefLabel
Disparities in the use of a mH ...... e adults with type 2 diabetes.
@en
Disparities in the use of a mH ...... e adults with type 2 diabetes.
@nl
P2093
P2860
P921
P356
P1476
Disparities in the use of a mH ...... e adults with type 2 diabetes.
@en
P2093
Kevin B Johnson
Lyndsay A Nelson
Shelagh A Mulvaney
Yun-Xian Ho
P2860
P356
10.1093/JAMIA/OCV082
P577
2015-07-17T00:00:00Z